Phase Scientific’s CEO says his team is working on rapid test that can yield results in 10 to 15 minutes by finger pricking
Hong Kong is developing a rapid test for chikungunya fever that could detect the disease at an earlier stage, as part of the city’s efforts to harness technology to combat the public health risk.
Ricky Chiu Yin-to, founder and CEO of biotechnology company Phase Scientific, said on Monday that his team was working to develop a rapid blood test that could yield results in 10 to 15 minutes by finger pricking.
The test being developed in Hong Kong aims to detect the antigen, specific proteins on the surface of the chikungunya virus, instead of looking for antibodies produced by the body – an approach adopted by many other rapid tests in the world.
Your personal data will be processed and information from your device (cookies, unique identifiers, and other device data) may be stored by, accessed by and shared with 88 TCF vendor(s) and 20 ad partner(s), or used specifically by this site or app.
